J. Silva and . Da, toulouse-decouverte-majeure-sur-les-maladies-infectieuses, CNRS Toulouse Leishmania/Cycle parasitaire des Leishmanioses Photo DP/CDC/Alexander, 2013.

L. Pape and P. , Development of new antileishmanial drugs ??? current knowledge and future prospects, Journal of Enzyme Inhibition and Medicinal Chemistry, vol.17, issue.5, p.708, 2008.
DOI : 10.1080/14756360600700517

S. K. Bhattacharya, P. K. Sinha, S. Sundar, C. P. Thakur, T. K. Jha et al., series, 591. 96 Control of the leishmaniases: report of a meeting of the WHO Expert Committee on the Control of Leishmaniases WHO Expert Committee on the Control of the Leishmaniases, p.31, 2007.

. Pour-la-suite, nous nous sommes intéressés uniquement aux protéines kinases ciblées dans nos travaux, appartenant à la famille des STKs et qui sont CDK2

E. B. Grant, D. Guiadeen, E. Z. Baum, B. D. Foleno, H. Jin et al., The synthesis and SAR of rhodanines as novel class C ??-lactamase inhibitors, Bioorganic & Medicinal Chemistry Letters, vol.10, issue.19, p.2179, 2000.
DOI : 10.1016/S0960-894X(00)00444-3